Company Filing History:
Years Active: 2015-2018
Title: Kevin Millea: Innovator in Glycoprotein Research
Introduction
Kevin Millea is a notable inventor based in Saugus, MA (US). He has made significant contributions to the field of glycoprotein research, holding 2 patents that showcase his innovative approaches.
Latest Patents
Millea's latest patents focus on N-acetylhexosamine-containing N-glycans in glycoprotein products. The inventions provide methods for evaluating a glycoprotein preparation for the absence, presence, or amount of an N-acetylhexosamine glycan, such as an N-acetylglucosamine glycan. These advancements are crucial for enhancing the quality and efficacy of glycoprotein products.
Career Highlights
Kevin Millea is currently employed at Momenta Pharmaceuticals, Inc., where he applies his expertise in glycoprotein research. His work contributes to the development of innovative pharmaceutical solutions that can improve patient outcomes.
Collaborations
Millea collaborates with talented professionals in his field, including Nathaniel J Washburn and Enrique Arevalo. These partnerships foster a creative environment that drives innovation and research excellence.
Conclusion
Kevin Millea's contributions to glycoprotein research and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence advancements in the field, paving the way for future innovations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.